Express Pharma

Path to progress

On India’s 75th Independence Day, a few stakeholders and their partners share their insights on the biggest achievements and learnings for the industry since Independence and the way forward for India Pharma Inc

0 724

The industry must continue to take strides towards innovation, by coming up with effective new drugs for unmet and emerging healthcare needs

Glenn Saldanha, Chairman & MD, Glenmark

The Indian pharma industry has witnessed some significant milestones over the past decades since Independence and has become one of the leading providers of medicines to the world population. At the same time, there have been several lessons and learnings for the sector. One of the key learnings, particularly during COVID-19, is for the industry to be self-reliant with respect to life-saving drugs. The Indian government’s support schemes for the pharma industry as part of its push to achieve an Atmanirbhar Bharat is a decision in the right direction. This will further encourage domestic manufacturing while ensuring an uninterrupted supply of medicines.

Digitisation has, in recent years, become another key driver for the industry, enabling better management of complexities in these uncertain times. We expect it to play a crucial role in driving agility across the pharma value chain by bringing the industry closer to doctors and patients. Lastly, the industry must continue to take strides towards innovation, by coming up with effective new drugs for unmet and emerging healthcare needs. Steps in this direction will help transform the Indian Pharma industry into a global innovation hub for the future.


A constant focus on research and innovation is vital since diseases in future will be different from the ones we know today

Dr Sharvil Patel, MD, Zydus Group

The COVID-19 pandemic has highlighted the need to make the healthcare systems integrated, more robust and rapidly scalable. This will help quicken the turnaround time in case of a future crisis. Also, a constant focus on research and innovation is vital since diseases in the future will be quite different from the ones we know today. Tackling the pandemics of the future will require large scale infrastructure and rapid scalability in terms of  manufacturing of critical drugs. India has a critical role to play as a reliable supplier of vaccines and therapeutics which are affordable to patients in India and across the world. We must continue to build on this strength.


Pharma industry needs to partner with key stakeholders, erasing traditional boundaries to chart out its next phase of growth